AZT

DRUG2 trials

Sponsors

Johns Hopkins Bloomberg School of Public Health, Michael Hoelscher

Conditions

HIV InfectionsHIV-1 Infection

Phase 2

A Trial to Confirm a Sustained Virological Suppression Defined as HIV-RNA <50 Copies/ml of 3 Different Doses of Fozivudine in Context to a Standard Zidovudine Based Antiretroviral Therapy Regimen

CompletedNCT01714414

Michael HoelscherHIV-1 Infection

Start: 2012-12-31End: 2017-02-28Updated: 2018-03-07

Phase 3

Extended Infant Post-exposure Prophylaxis With Antiretrovirals to Reduce Postnatal HIV Transmission

CompletedNCT00115648

Johns Hopkins Bloomberg School of Public HealthHIV Infections

Start: 2004-04-30End: 2009-10-31Target: 3300Updated: 2014-03-07

Related Papers

Maternal Highly Active Antiretroviral Therapy and Child HIV-Free Survival in Malawi, 2004-2009.

2016-03-015 citations

Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission.

2008-06-04263 citations